Register for a live broadcast to learn more about TRODELVY (sacituzumab govitecan-hziy) with Dr. Hope S. Rugo

Prostate Cancer Diagnoses Decrease With Lenient Screening Recommendations

Wednesday, May 08, 2019

After the United States Preventative Services Task Force (USPSTF) recommended against all men being screened for prostate cancer, there was a decrease in the incidence around the nation, according to MaryBeth Freeman, MPH, senior associate scientist at the American Cancer Society. 

Freeman also emphasized that the USPSTF updated their guidelines again in 2018 to state that men should have thorough discussions with their healthcare providers about the risks and benefits of prostate cancer screening, as it pertains to them individually. This will prevent over-screening in this population, while also ensuring that men who may be at risk for the disease are still getting the appropriate screening and potential diagnosis. 

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.